Antiviral drugs in hospitalized patients with COVID-19 - the DisCoVeRy trial

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro2020 · 2,195 citations
2. 2Interferon-β-1a Inhibition of Severe Acute Respiratory Syndrome–Coronavirus 2 In Vitro When Administered After Virus Infection2020 · 69 citations
3. 3Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro2020 · 7,406 citations
4. 4Coronavirus Disease 19 Infection Does Not Result in Acute Kidney Injury: An Analysis of 116 Hospitalized Patients from Wuhan, China2020 · 464 citations
5. 5Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-192020 · 1,128 citations